TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 14692951

Group type: EXPERIMENTAL
Intervention: Stapled haemorrhoidectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional haemorrhoidectomy
Number of subjects: 0
Study: 11375295

Group type: EXPERIMENTAL
Intervention: Calcium alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium plus low doses of conjugated equine estrogen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium plus conventional doses of conjugated equine estrogen
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium plus low doses of calcitriol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium plus conventional doses of calcitriol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 10085993

Group type: EXPERIMENTAL
Intervention: COPE program
Number of subjects: 0
Study: 9366972

Group type: EXPERIMENTAL
Intervention: Peptide T high dose (15 mg daily for four weeks)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Peptide T low dose (1.5 mg daily for four weeks)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Comparison of high dose versus low dose Peptide T
Number of subjects: 9
Study: 1760535

Group type: EXPERIMENTAL
Intervention: Felodipine 1.25 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Felodipine 10 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 7046411

Group type: EXPERIMENTAL
Intervention: Brown rice
Number of subjects: 12

Group type: COMPARATOR
Intervention: Ground brown rice
Number of subjects: 12

Group type: COMPARATOR
Intervention: Glucose
Number of subjects: 12
Study: 30716404

Group type: EXPERIMENTAL
Intervention: 300 mg secukinumab
Number of subjects: 237

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 237
Study: 28450529

Group type: EXPERIMENTAL
Intervention: Reactive phenotype
Number of subjects: 454

Group type: EXPERIMENTAL
Intervention: Uninflamed phenotype
Number of subjects: 454
Study: 27807110

Group type: EXPERIMENTAL
Intervention: 36-mm metal-on-XLPE articulation
Number of subjects: 56

Group type: COMPARATOR
Intervention: 28-mm metal-on-XLPE articulation
Number of subjects: 56
Study: 23425517

Group type: EXPERIMENTAL
Intervention: Combined intervention of stress management techniques and dietary education (Mediterranean diet principle)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 36
Study: 22310190

Group type: EXPERIMENTAL
Intervention: Virtual Fiberoptic Intubation (VFI) software
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (usual didactic method only)
Number of subjects: 23
Study: 20615108

Group type: EXPERIMENTAL
Intervention: SMS-based insulin dose titration system
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional titration scheme
Number of subjects: 100
Study: 18261788

Group type: EXPERIMENTAL
Intervention: Interventions to improve asthma control; specific interventions not detailed in the abstract.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable; control group not specified.
Number of subjects: 0
Study: 15632102

Group type: EXPERIMENTAL
Intervention: Pioglitazone 45 mg/day
Number of subjects: 23

Group type: COMPARATOR
Intervention: Metformin 2,000 mg/day
Number of subjects: 23
Study: 12787301

Group type: EXPERIMENTAL
Intervention: Montelukast 5 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 10573242

Group type: EXPERIMENTAL
Intervention: Combination therapy with salmeterol (50 microg b.i.d.) and beclomethasone (400 microg b.i.d.)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Monotherapy with beclomethasone (400 microg b.i.d.)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Monotherapy with salmeterol (50 microg b.i.d.)
Number of subjects: 40
Study: 9127726

Group type: EXPERIMENTAL
Intervention: Oxcarbazepine (OXC)
Number of subjects: 249

Group type: COMPARATOR
Intervention: Sodium Valproate (VPA)
Number of subjects: 249
Study: 1540456

Group type: EXPERIMENTAL
Intervention: Uncontrolled IUP during surgery (first part of the study)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Uncontrolled IUP during surgery (second part of the study)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Controlled IUP during surgery
Number of subjects: 26
Study: 3987929

Group type: EXPERIMENTAL
Intervention: Pergolide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo/Control
Number of subjects: 0
Study: 31221292

Group type: EXPERIMENTAL
Intervention: Ad libitum Mediterranean diet (MedDiet)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 65
Study: 27633943

Group type: EXPERIMENTAL
Intervention: Relax to Sleep (RTS) intervention
Number of subjects: 48

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 48
Study: 27050252

Group type: EXPERIMENTAL
Intervention: Vitamin D-K-Calcium co-supplementation (200 IU vitamin D, 90 μg vitamin K, 500 mg calcium)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 24689093

Group type: EXPERIMENTAL
Intervention: Unsedated transnasal endoscopy (TNE)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Unsedated transoral endoscopy (TOE)
Number of subjects: 100
Study: 23089445

Group type: EXPERIMENTAL
Intervention: Bioabsorbable staple-line reinforcement (Seamguard) during stapled hemorrhoidopexy (Group A)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard stapled hemorrhoidopexy without reinforcement (Group B)
Number of subjects: 100
Study: 19603621

Group type: EXPERIMENTAL
Intervention: TMS‐2 Topography System
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Keratron Scout
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Pentacam
Number of subjects: 71
Study: 17877601

Group type: EXPERIMENTAL
Intervention: Misoprostol 200 microg rectally (Group A)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Misoprostol 400 microg rectally (Group B)
Number of subjects: 80

Group type: COMPARATOR
Intervention: No drugs (Group C)
Number of subjects: 80
Study: 15085026

Group type: EXPERIMENTAL
Intervention: Nizatidine (2 or 4 mg/kg i.v. for infants; 2.5 or 5 mg/kg oral for children; 150 mg capsule for adolescents and adults)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Nizatidine administration
Number of subjects: 129
Study: 11673341

Group type: EXPERIMENTAL
Intervention: Stent implantation
Number of subjects: 351

Group type: COMPARATOR
Intervention: Angioplasty alone
Number of subjects: 351
Study: 8501628

Group type: EXPERIMENTAL
Intervention: Heparin-surface-modified (HSM) intraocular lenses (IOLs)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional poly(methyl methacrylate) (PMMA) intraocular lenses (IOLs)
Number of subjects: 40
Study: 3329126

Group type: EXPERIMENTAL
Intervention: Sucrose-enriched diet (about 20 g sucrose per day)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional diet
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sucrose-enriched diet
Number of subjects: 10
Study: 31912903

Group type: EXPERIMENTAL
Intervention: Oral hygiene regimen (OHR) for 2 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: PBS(−/−) control
Number of subjects: 30
Study: 29214461

Group type: EXPERIMENTAL
Intervention: CHO‐C (Carbohydrate + Sodium Caseinate Protein)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: CHO‐H (Carbohydrate + Sodium Caseinate Protein Hydrolysate)
Number of subjects: 11

Group type: COMPARATOR
Intervention: CHO (Carbohydrate)
Number of subjects: 11
Study: 28787506

Group type: EXPERIMENTAL
Intervention: Azithromycin (250 mg, 3 times a week for 2 years)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 480
Study: 26245599

Group type: EXPERIMENTAL
Intervention: Multiforce® (MF) Alkaline Powder, 7.5 g twice daily
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 23117443

Group type: EXPERIMENTAL
Intervention: Standard aftercare plus biweekly telephone monitoring and support for three months after discharge
Number of subjects: 837

Group type: COMPARATOR
Intervention: Standard outpatient aftercare
Number of subjects: 837

Group type: EXPERIMENTAL
Intervention: Both groups (telephone monitoring and treatment as usual)
Number of subjects: 837

Group type: EXPERIMENTAL
Intervention: Telephone care management
Number of subjects: 837
Study: 20602331

Group type: EXPERIMENTAL
Intervention: Online hemodiafiltration (OL-HDF)
Number of subjects: 906

Group type: COMPARATOR
Intervention: Standard hemodialysis (HD)
Number of subjects: 906
Study: 18428211

Group type: EXPERIMENTAL
Intervention: Lamotrigine (target dose of 300 mg/day)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study: 16597731

Group type: EXPERIMENTAL
Intervention: Hand-object illusion (vibrated tendon of the wrist extensor muscle while touching an object)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control 1 (vibrated skin surface over nearby bone)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control 2 (vibrated tendon when hand did not touch the object)
Number of subjects: 12
Study: 12588325

Group type: EXPERIMENTAL
Intervention: ATG
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: OKT3
Number of subjects: 55
Study: 10638899

Group type: EXPERIMENTAL
Intervention: Sevoflurane at concentrations ranging from 0.45% to 0.85%
Number of subjects: 96
Study: 9338951

Group type: EXPERIMENTAL
Intervention: Diet
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Diet and exercise
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 208

Group type: COMPARATOR
Intervention: No active intervention
Number of subjects: 208
Study: 8247917

Group type: EXPERIMENTAL
Intervention: Combination therapy with DTZ SR-HCTZ 120 mg-12.5 mg
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Monotherapy with DTZ SR 120 mg
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Monotherapy with HCTZ 12.5 mg
Number of subjects: 298

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 298
Study: 3479525

Group type: EXPERIMENTAL
Intervention: Lecithin treatment
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 31299247

Group type: EXPERIMENTAL
Intervention: Oropharyngeal spray (10 actuations of 10% lignocaine, group B)
Number of subjects: 1050
Study: 29120964

Group type: EXPERIMENTAL
Intervention: vemurafenib
Number of subjects: 1310

Group type: EXPERIMENTAL
Intervention: ipilimumab
Number of subjects: 1310

Group type: EXPERIMENTAL
Intervention: dabrafenib
Number of subjects: 1310
Study: 28182565

Group type: EXPERIMENTAL
Intervention: Dyspnoea-12 (D-12)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Multidimensional Dyspnoea Profile (MDP)
Number of subjects: 84

Group type: COMPARATOR
Intervention: D-12 and MDP
Number of subjects: 84
Study: 26224811

Group type: EXPERIMENTAL
Intervention: Extracranial systemic embolic events (SEEs)
Number of subjects: 37973

Group type: COMPARATOR
Intervention: Stroke
Number of subjects: 37973

Group type: EXPERIMENTAL
Intervention: SEEs involving lower extremity
Number of subjects: 37973

Group type: EXPERIMENTAL
Intervention: SEEs involving visceral-mesenteric
Number of subjects: 37973

Group type: EXPERIMENTAL
Intervention: SEEs involving upper extremity
Number of subjects: 37973

Group type: EXPERIMENTAL
Intervention: SEE-related care
Number of subjects: 37973

Group type: EXPERIMENTAL
Intervention: Recovery within 30 days after SEE
Number of subjects: 37973

Group type: EXPERIMENTAL
Intervention: Thirty-day mortality after SEE
Number of subjects: 37973

Group type: EXPERIMENTAL
Intervention: Relative risk of death after SEE
Number of subjects: 37973

Group type: COMPARATOR
Intervention: Relative risk of death after stroke
Number of subjects: 37973
Study: 22878377

Group type: EXPERIMENTAL
Intervention: Unilateral fixation
Number of subjects: 116

Group type: COMPARATOR
Intervention: Bilateral fixation
Number of subjects: 116
Study: 22040388

Group type: EXPERIMENTAL
Intervention: Computer-tailored intervention (CTI) based on the transtheoretical model (TTM)
Number of subjects: 350
Study: 19639073

Group type: COMPARATOR
Intervention: Kukident Classic (control adhesive)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Kukident Pro (experimental adhesive)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Nonadhesive group
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Maxillary and mandibular dentures (both adhesive groups)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Subjective evaluation of both adhesives
Number of subjects: 24
Study: 17468862

Group type: EXPERIMENTAL
Intervention: Curcumin (300 mg day(-1) for 6 days)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Talinolol (50 mg single oral dose)
Number of subjects: 12
Study: 15041571

Group type: EXPERIMENTAL
Intervention: IV-ECG guidance (Group E)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Surface landmark technique (Group S)
Number of subjects: 60
Study: 11783748

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing techniques
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard evaluation
Number of subjects: 60
Study: 9000151

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 8489440

Group type: EXPERIMENTAL
Intervention: Prophylactic surfactant therapy
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control (no prophylactic surfactant)
Number of subjects: 86
Study: 3829723

Group type: EXPERIMENTAL
Intervention: Aqueous anthralin cream (Drithocreme) applied overnight
Number of subjects: 20

Group type: COMPARATOR
Intervention: Aqueous anthralin cream (Drithocreme) applied for thirty minutes
Number of subjects: 20
Study: 29164444

Group type: EXPERIMENTAL
Intervention: START program (20-week multi-component socialization intervention)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 40
Study: 27256720

Group type: EXPERIMENTAL
Intervention: SIIIN2
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: SIIIDTG
Number of subjects: 65
Study: 24447053

Group type: EXPERIMENTAL
Intervention: High-frequency repetitive transcranial magnetic stimulation (HF-rTMS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 20
Study: 23526939

Group type: EXPERIMENTAL
Intervention: Newly developed eGFR formulas (eGFR7 and eGFR8) using serum CysC detection alone or in combination with serum Cr detection
Number of subjects: 788

Group type: COMPARATOR
Intervention: eGFR1 (Cockcroft-Gault equation)
Number of subjects: 788

Group type: COMPARATOR
Intervention: eGFR2 (MDRD formula)
Number of subjects: 788

Group type: COMPARATOR
Intervention: eGFR3 (CKD-EPI formula)
Number of subjects: 788

Group type: COMPARATOR
Intervention: eGFR4 (CKD-EPI formula)
Number of subjects: 788

Group type: COMPARATOR
Intervention: eGFR5 (Chinese eGFR Investigation Collaboration formula)
Number of subjects: 788

Group type: COMPARATOR
Intervention: eGFR6 (Chinese eGFR Investigation Collaboration formula)
Number of subjects: 788

Group type: EXPERIMENTAL
Intervention: eGFR7 and eGFR8
Number of subjects: 788
Study: 20543286

Group type: EXPERIMENTAL
Intervention: High extraversion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Social exclusion and existential anxiety
Number of subjects: 0
Study: 17543392

Group type: EXPERIMENTAL
Intervention: Group treatment
Number of subjects: 130

Group type: COMPARATOR
Intervention: Internet-based treatment
Number of subjects: 130
Study: 15722381

Group type: EXPERIMENTAL
Intervention: Catheter over-needle technique (22G Spinocath, B. Braun, Germany)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Catheter through-needle technique (MicroCatheter, Portex, UK)
Number of subjects: 18
Study: 12959681

Group type: EXPERIMENTAL
Intervention: Ticarcillin/clavulanic acid (T)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Ceftriaxone plus amikacin (C+A)
Number of subjects: 70
Study: 10549683

Group type: EXPERIMENTAL
Intervention: Zolpidem, 10 mg nightly for 4 weeks
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 8895263

Group type: EXPERIMENTAL
Intervention: Desflurane (Group 4)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sevoflurane (Group 1)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Halothane (Group 2)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Halothane (Group 3)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 80
Study: 2050833

Group type: EXPERIMENTAL
Intervention: Moclobemide (100 mg TID)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Phenelzine (15 mg TID)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Norepinephrine
Number of subjects: 12
Study: 6219902

Group type: EXPERIMENTAL
Intervention: Erythromycin stearate tablets (500 mg twice a day for 2 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Erythromycin enteric-coated base capsules (500 mg twice a day for 2 weeks)
Number of subjects: 20
Study: 31308105

Group type: EXPERIMENTAL
Intervention: Addition of a non‐directional educational message on the risk of ionising radiation to all CT reports
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control hospital (no intervention)
Number of subjects: 0
Study: 30119152

Group type: EXPERIMENTAL
Intervention: Volume-controlled equal ratio ventilation (VC-ERV)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Volume-controlled conventional ratio ventilation (VC-CRV)
Number of subjects: 111
Study: 26778138

Group type: EXPERIMENTAL
Intervention: Compression garments (full‐length compression top and compression shorts) during exercise and overnight recovery
Number of subjects: 10

Group type: COMPARATOR
Intervention: Normal work clothes (control condition)
Number of subjects: 10
Study: 24578164

Group type: EXPERIMENTAL
Intervention: Resynchronization therapy (CRT-D)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 191
Study: 22128223

Group type: EXPERIMENTAL
Intervention: Eplerenone
Number of subjects: 5792

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5792
Study: 19053987

Group type: EXPERIMENTAL
Intervention: pantoprazole 80 mg + 8 mg/h for 72 h
Number of subjects: 1256

Group type: COMPARATOR
Intervention: ranitidine 50 mg + 13 mg/h for 72 h
Number of subjects: 1256
Study: 16891136

Group type: EXPERIMENTAL
Intervention: levalbuterol 0.31 mg via nebulizer
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: levalbuterol 0.63 mg via nebulizer
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: racemic albuterol 1.25 mg via nebulizer
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: racemic albuterol 2.5 mg via nebulizer
Number of subjects: 262

Group type: COMPARATOR
Intervention: (S)-albuterol presence
Number of subjects: 262
Study: 15088306

Group type: EXPERIMENTAL
Intervention: 25 mg (2.5 ml) hyaluronan (HA) in a phosphate buffered solution
Number of subjects: 240

Group type: COMPARATOR
Intervention: Saline vehicle (2.5 ml vehicle containing only the buffer)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Intraarticular HA treatment
Number of subjects: 240
Study: 11293751

Group type: EXPERIMENTAL
Intervention: Ligation plus APC
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ligation alone
Number of subjects: 60
Study: 9635603

Group type: EXPERIMENTAL
Intervention: Indomethacin (50 mg three times a day)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium (50 mg three times a day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 8159153

Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV)
Number of subjects: 7000
Study: 3042126

Group type: EXPERIMENTAL
Intervention: Flunarizine (15 mg/day)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 30744880

Group type: EXPERIMENTAL
Intervention: Omega-3 LCPUFA (722 mg/day DHA)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Vitamin D (2000 IU/day)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Vitamin D (2000 IU/day) + Omega-3 LCPUFA (722 mg/day DHA)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study: 28097633

Group type: EXPERIMENTAL
Intervention: Individualized meropenem therapy based on a population PK/PD model
Number of subjects: 79

Group type: COMPARATOR
Intervention: Standard meropenem regimen decided by the attending physician
Number of subjects: 79
Study: 25496795

Group type: EXPERIMENTAL
Intervention: Wiggio (W) group
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control (C) group
Number of subjects: 14
Study: 24021179

Group type: EXPERIMENTAL
Intervention: Quatrix IOL
Number of subjects: 67

Group type: COMPARATOR
Intervention: AR40e IOL
Number of subjects: 67
Study: 21508849

Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 106

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 106
Study: 17989918

Group type: EXPERIMENTAL
Intervention: Acupuncture (AC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control acupuncture (controlAC)
Number of subjects: 40
Study: 15175633

Group type: EXPERIMENTAL
Intervention: Sour milk fermented with Lactobacillus helveticus containing 2.4-2.7 mg of Ile-Pro-Pro and 2.4-2.7 mg of Val-Pro-Pro per 1.5 dl, taken daily.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (regular sour milk), taken daily.
Number of subjects: 60
Study: 12538116

Group type: EXPERIMENTAL
Intervention: CorLink device for anastomosis between saphenous vein and ascending aorta
Number of subjects: 21

Group type: COMPARATOR
Intervention: 6-0 running suture for central bypass anastomosis
Number of subjects: 21
Study: 9719049

Group type: EXPERIMENTAL
Intervention: NPH insulin (0.3 U/kg body wt per day)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Insulin infusion
Number of subjects: 23